The CEO of Germany’s Bayer AG is promising it won’t use its planned acquisition of Monsanto Co. to force genetically modified crops on skeptical Europeans.
Creve Coeur-based Monsanto in September accepted an offer from Bayer to pay $57 billion to its shareholders and assume $9 billion in debt. The combination would create a global agricultural and chemical giant — and bring Bayer together with a leading producer of genetically modified seeds that are engineered to resist drought, among other things, but viewed with deep suspicion in Europe.
Bayer CEO Werner Baumann was quoted Monday as telling German daily Süddeutsche Zeitung: “We don’t want to take over Monsanto in order to establish genetically modified plants in Europe.” He added that Bayer accepts European resistance “even if we are of a different opinion.”
Full Content: St. Louis Post
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Turkish Antitrust Authority Approves Tofaş Takeover of Stellantis Distribution Unit
Apr 20, 2025 by
CPI
Ohio Sues United Wholesale Mortgage Over Alleged Broker Collusion
Apr 20, 2025 by
CPI
Italy Reconsiders Digital Services Tax as US Tech Pressure Mounts
Apr 20, 2025 by
CPI
Japan’s Antitrust Regulator to Warn Top Tokyo Hotels Over Pricing Information Sharing
Apr 20, 2025 by
CPI
Senate Judiciary Committee Advances Bipartisan Bills to Address Drug Pricing and Competition
Apr 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Airline Industry
Apr 10, 2025 by
CPI
Boosting Competition in International Aviation
Apr 10, 2025 by
Jeffrey N. Shane
Reshaping Competition Policy for the U.S. Airline Industry
Apr 10, 2025 by
Diana L. Moss
Algorithmic Collusion in the Skies: The Role of AI in Shaping Airline Competition
Apr 10, 2025 by
Qi Ge, Myongjin Kim & Nicholas Rupp
Competition in U.S. Airline Markets: Major Developments and Economic Insights
Apr 10, 2025 by
Germán Bet